Juno News 337 views Sep 04, 2017
Destiny Pharma IPO
We were delighted to attend the LSE this morning to see Destiny Pharma, a Juno Capital portfolio company, welcomed to the AIM Market.
 
The day has seen the company well received by the market and, at the time of writing, was trading approximately 40% up on the bell.
 
More commentary to follow over the coming days.